Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)

Asthma is a variable chronic respiratory disease characterized by airway inflammation and hyperresponsiveness, bronchoconstriction, and mucus hypersecretion. While most patients with asthma achieve good control of the disease, 5-10% experience severe symptoms and recurrent exacerbation despite the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Fildan, Ariadna Petronela, Rajnoveanu, Ruxandra-Mioara, Cirjaliu, Roxana, Pohrib, Ionela, Tudorache, Emanuela, Ilie, Adrian Cosmin, Oancea, Cristian, Tofolean, Doina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453334/
https://www.ncbi.nlm.nih.gov/pubmed/34603531
http://dx.doi.org/10.3892/etm.2021.10698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453334/
https://www.ncbi.nlm.nih.gov/pubmed/34603531
http://dx.doi.org/10.3892/etm.2021.10698

Ejemplares similares